| CVX |
CVX Label |
Use Status |
TCH |
TCH Label |
Comment |
| 801 |
AS03 Adjuvant |
NOT SUPPORTED |
|
|
|
| 143 |
Adenovirus types 4 and 7 |
NOT SUPPORTED |
|
|
|
| 19 |
BCG |
NOT SUPPORTED |
211 |
BCG |
|
| 29 |
CMVIG |
NOT SUPPORTED |
1070 |
CMVIG |
|
| 28 |
DT (pediatric) |
SUPPORTED |
112 |
DT |
|
| 01 |
DTP |
SUPPORTED |
111 |
DTP |
|
| 22 |
DTP-Hib |
SUPPORTED |
121 |
DTP-Hib |
|
| 102 |
DTP-Hib-Hep B |
SUPPORTED |
1150 |
DTP-Hib-Hep B |
|
| 20 |
DTaP |
SUPPORTED |
110 |
DTaP |
|
| 106 |
DTaP, 5 pertussis antigens |
SUPPORTED |
110 |
DTaP |
|
| 107 |
DTaP, unspecified formulation |
SUPPORTED |
110 |
DTaP |
|
| 146 |
DTaP,IPV,Hib,HepB |
SUPPORTED |
142 |
DTaP-IPV-HIB-HepB |
|
| 110 |
DTaP-Hep B-IPV |
SUPPORTED |
114 |
DTaP-HepB-IPV |
|
| 50 |
DTaP-Hib |
SUPPORTED |
113 |
DTaP-Hib |
|
| 120 |
DTaP-Hib-IPV |
SUPPORTED |
115 |
DTaP-Hib-IPV |
|
| 130 |
DTaP-IPV |
SUPPORTED |
116 |
DTaP-IPV |
|
| 132 |
DTaP-IPV-HIB-HEP B, historical |
SUPPORTED |
142 |
DTaP-IPV-HIB-HepB |
|
| 170 |
DTaP/IPV/Hib |
SUPPORTED |
227 |
DTaP/IPV/HIB |
|
| 30 |
HBIG |
NOT SUPPORTED |
1230 |
HBIG |
|
| 61 |
HIV |
NOT SUPPORTED |
|
|
|
| 118 |
HPV, bivalent |
SUPPORTED |
391 |
HPV,bivalent |
|
| 62 |
HPV, quadrivalent |
SUPPORTED |
390 |
HPV,quadrivalent |
|
| 137 |
HPV, unspecified formulation |
SUPPORTED |
391 |
HPV,bivalent |
|
| 165 |
HPV9 |
SUPPORTED |
214 |
HPV9 |
|
| 154 |
Hep A, IG |
NOT SUPPORTED |
|
|
|
| 52 |
Hep A, adult |
SUPPORTED |
1170 |
Hep A, adult |
|
| 83 |
Hep A, ped/adol, 2 dose |
SUPPORTED |
1180 |
Hep A, ped/adol, 2 dose |
|
| 84 |
Hep A, ped/adol, 3 dose |
SUPPORTED |
1190 |
Hep A, ped/adol, 3 dose |
|
| 31 |
Hep A, pediatric, unspecified formulation |
SUPPORTED |
145 |
Hep A |
|
| 85 |
Hep A, unspecified formulation |
SUPPORTED |
145 |
Hep A |
|
| 104 |
Hep A-Hep B |
SUPPORTED |
146 |
Hep A-Hep B |
|
| 08 |
Hep B, adolescent or pediatric |
SUPPORTED |
1240 |
Hep B, adolescent or pediatric |
|
| 42 |
Hep B, adolescent/high risk infant |
SUPPORTED |
1250 |
Hep B, adolescent/high risk infant |
|
| 43 |
Hep B, adult |
SUPPORTED |
1260 |
Hep B, adult |
|
| 44 |
Hep B, dialysis |
SUPPORTED |
1270 |
Hep B, dialysis |
|
| 45 |
Hep B, unspecified formulation |
SUPPORTED |
137 |
Hep B |
|
| 58 |
Hep C |
NOT SUPPORTED |
|
|
|
| 59 |
Hep E |
NOT SUPPORTED |
1300 |
Hep E |
|
| 47 |
Hib (HbOC) |
SUPPORTED |
1330 |
Hib (HbOC) |
|
| 46 |
Hib (PRP-D) |
SUPPORTED |
1320 |
Hib (PRP-D) |
|
| 49 |
Hib (PRP-OMP) |
SUPPORTED |
1350 |
Hib (PRP-OMP) |
|
| 48 |
Hib (PRP-T) |
SUPPORTED |
1340 |
Hib (PRP-T) |
|
| 17 |
Hib, unspecified formulation |
SUPPORTED |
128 |
Hib |
|
| 51 |
Hib-Hep B |
SUPPORTED |
136 |
Hib-Hep B |
|
| 86 |
IG |
NOT SUPPORTED |
1400 |
IG |
|
| 14 |
IG, unspecified formulation |
NOT SUPPORTED |
1420 |
IG, NOS |
|
| 87 |
IGIV |
NOT SUPPORTED |
1410 |
IGIV |
|
| 10 |
IPV |
SUPPORTED |
147 |
IPV |
|
| 160 |
Influenza A monovalent (H5N1), ADJUVANTED-2013 |
NOT SUPPORTED |
|
|
|
| 153 |
Influenza, IIV3 MDCK |
SUPPORTED |
229 |
Influenza, IIV3 MDCK |
|
| 135 |
Influenza, high dose seasonal |
SUPPORTED |
185 |
Influenza IIV3, high dose >65 years |
|
| 171 |
Influenza, injectable, MDCK, trivalent |
SUPPORTED |
219 |
Flucelvax, injectable, quadrivalent, preservative free |
|
| 161 |
Influenza, injectable,quadrivalent, preservative free, pediatric |
SUPPORTED |
204 |
Influenza IIV4 |
|
| 141 |
Influenza, seasonal, injectable |
SUPPORTED |
201 |
Influenza IIV3 NOS |
|
| 140 |
Influenza, seasonal, injectable, preservative free |
SUPPORTED |
200 |
Influenza IIV3 PF |
|
| 134 |
Japanese Encephalitis IM |
NOT SUPPORTED |
1491 |
Japanese Encephalitis-IM |
|
| 129 |
Japanese Encephalitis, unspecified formulation |
NOT SUPPORTED |
|
|
|
| 39 |
Japanese encephalitis SC |
NOT SUPPORTED |
1490 |
Japanese Encephalitis-SC |
|
| 63 |
Junin virus |
NOT SUPPORTED |
|
|
|
| 66 |
Lyme disease |
NOT SUPPORTED |
209 |
Lyme disease |
|
| 04 |
M/R |
SUPPORTED |
160 |
M/R |
|
| 03 |
MMR |
SUPPORTED |
158 |
MMR |
|
| 94 |
MMRV |
SUPPORTED |
159 |
MMRV |
|
| 148 |
Meningococcal C/Y-HIB PRP |
SUPPORTED |
213 |
Meningococcal C/Y-HIB PRP |
|
| 136 |
Meningococcal MCV4O |
SUPPORTED |
198 |
MCV4 (Menveo) |
|
| 128 |
Novel Influenza-H1N1-09, all formulations |
SUPPORTED |
186 |
Novel H1N1-09,NOS |
|
| 125 |
Novel Influenza-H1N1-09, nasal |
SUPPORTED |
187 |
Novel H1N1-09,Live,Nasal |
|
| 127 |
Novel influenza-H1N1-09 |
SUPPORTED |
189 |
Novel H1N1-09,Injectable |
|
| 126 |
Novel influenza-H1N1-09, preservative-free |
SUPPORTED |
188 |
Novel H1N1-09,Injectable,Presv-free |
|
| 02 |
OPV |
SUPPORTED |
148 |
OPV |
|
| 152 |
Pneumococcal Conjugate, unspecified formulation |
SUPPORTED |
156 |
Pneumococcal,NOS |
|
| 133 |
Pneumococcal conjugate PCV 13 |
SUPPORTED |
3143 |
Pneumococcal, PCV-13 |
|
| 70 |
Q fever |
NOT SUPPORTED |
1680 |
Q fever |
|
| 99 |
RESERVED - do not use |
NOT SUPPORTED |
|
|
|
| 34 |
RIG |
NOT SUPPORTED |
1740 |
RIG |
|
| 71 |
RSV-IGIV |
NOT SUPPORTED |
1760 |
RSV-IGIV |
|
| 93 |
RSV-MAb |
NOT SUPPORTED |
1770 |
RSV-MAb |
|
| 145 |
RSV-MAb (new) |
NOT SUPPORTED |
|
|
|
| 159 |
Rho(D) - Unspecified formulation |
NOT SUPPORTED |
|
|
|
| 157 |
Rho(D) -IG IM |
NOT SUPPORTED |
|
|
|
| 156 |
Rho(D)-IG |
NOT SUPPORTED |
|
|
|
| 73 |
Rift Valley fever |
NOT SUPPORTED |
1730 |
Rift Valley fever |
|
| 76 |
Staphylococcus bacterio lysate |
NOT SUPPORTED |
1810 |
Staphylococcus bacterio lysate |
|
| 13 |
TIG |
NOT SUPPORTED |
1850 |
TIG |
|
| 98 |
TST, unspecified formulation |
NOT SUPPORTED |
1890 |
TST, NOS |
|
| 95 |
TST-OT tine test |
NOT SUPPORTED |
1860 |
TST-OT tine test |
|
| 96 |
TST-PPD intradermal |
NOT SUPPORTED |
1870 |
TST-PPD intradermal |
|
| 97 |
TST-PPD tine test |
NOT SUPPORTED |
1880 |
TST-PPD tine test |
|
| 138 |
Td (adult) |
SUPPORTED |
122 |
Td |
|
| 113 |
Td (adult) preservative free |
SUPPORTED |
124 |
Td No Prsrv |
|
| 09 |
Td (adult), adsorbed |
SUPPORTED |
122 |
Td |
|
| 139 |
Td(adult) unspecified formulation |
SUPPORTED |
122 |
Td |
|
| 115 |
Tdap |
SUPPORTED |
123 |
Tdap |
|
| 81 |
VEE, inactivated |
NOT SUPPORTED |
1980 |
VEE, inactivated |
|
| 80 |
VEE, live |
NOT SUPPORTED |
1990 |
VEE, live |
|
| 92 |
VEE, unspecified formulation |
NOT SUPPORTED |
2000 |
VEE, NOS |
|
| 36 |
VZIG |
SUPPORTED |
2010 |
VZIG |
Problem: No forecast series references this code |
| 117 |
VZIG (IND) |
NOT SUPPORTED |
|
|
|
| 187 |
Zoster |
SUPPORTED |
237 |
Zoster |
|
| 54 |
adenovirus, type 4 |
NOT SUPPORTED |
1000 |
adenovirus, type 4 |
|
| 55 |
adenovirus, type 7 |
NOT SUPPORTED |
1010 |
adenovirus, type 7 |
|
| 82 |
adenovirus, unspecified formulation |
NOT SUPPORTED |
1020 |
adenovirus, NOS |
|
| 24 |
anthrax |
NOT SUPPORTED |
1030 |
anthrax |
|
| 27 |
botulinum antitoxin |
NOT SUPPORTED |
1050 |
botulinum antitoxin |
|
| 26 |
cholera |
NOT SUPPORTED |
1060 |
cholera |
|
| 56 |
dengue fever |
NOT SUPPORTED |
1080 |
dengue fever |
|
| 12 |
diphtheria antitoxin |
NOT SUPPORTED |
1090 |
diphtheria antitoxin |
|
| 57 |
hantavirus |
NOT SUPPORTED |
1160 |
hantavirus |
|
| 60 |
herpes simplex 2 |
NOT SUPPORTED |
1310 |
herpes simplex 2 |
|
| 186 |
influenza injectable MDCK quadrivalent |
SUPPORTED |
222 |
Influenza injectable MDCK quadrivalent |
|
| 151 |
influenza nasal, unspecified formulation |
SUPPORTED |
220 |
Influenza nasal, unspecified formulation |
|
| 185 |
influenza recombinant quadrivalent preservative free |
SUPPORTED |
221 |
Influenza recombinant quadrivalent |
|
| 123 |
influenza, H5N1-1203 |
NOT SUPPORTED |
|
|
|
| 158 |
influenza, injectable, quadrivalent |
SUPPORTED |
205 |
influenza, injectable, quadrivalent |
|
| 150 |
influenza, injectable, quadrivalent, preservative free |
SUPPORTED |
204 |
Influenza IIV4 |
|
| 166 |
influenza, intradermal, quadrivalent, preservative free |
SUPPORTED |
217 |
Influenza, intradermal, quadrivalent, preservative free |
|
| 111 |
influenza, live, intranasal |
SUPPORTED |
180 |
Influenza LAIV3 |
|
| 149 |
influenza, live, intranasal, quadrivalent |
SUPPORTED |
203 |
Influenza LAIV4 Nasal |
|
| 144 |
influenza, seasonal, intradermal, preservative free |
SUPPORTED |
202 |
Influenza IIV3 >=18 years, intradermal |
|
| 15 |
influenza, split (incl. purified surface antigen) |
SUPPORTED |
181 |
Influenza IIV3, <3 yrs |
|
| 168 |
influenza, trivalent, adjuvanted |
SUPPORTED |
218 |
FLUAD, adjuvanted, trivalent, preservative free |
|
| 88 |
influenza, unspecified formulation |
SUPPORTED |
179 |
Influenza IIV3, NOS |
|
| 16 |
influenza, whole |
SUPPORTED |
179 |
Influenza IIV3, NOS |
|
| 155 |
influenza,recombinant,injectable,PF,trivalent |
SUPPORTED |
223 |
Influenza recombinant trivalent |
|
| 64 |
leishmaniasis |
NOT SUPPORTED |
1510 |
leishmaniasis |
|
| 65 |
leprosy |
NOT SUPPORTED |
1520 |
leprosy |
|
| 67 |
malaria |
NOT SUPPORTED |
1570 |
malaria |
|
| 05 |
measles |
SUPPORTED |
161 |
Measles |
|
| 68 |
melanoma |
NOT SUPPORTED |
1590 |
melanoma |
|
| 163 |
meningococcal B, OMV |
SUPPORTED |
216 |
meningococcal B, OMV |
|
| 162 |
meningococcal B, recombinant |
SUPPORTED |
215 |
meningococcal B, recombinant |
|
| 103 |
meningococcal C conjugate |
NOT SUPPORTED |
197 |
Meningococcal C conjugate |
|
| 147 |
meningococcal MCV4, unspecified formulation |
SUPPORTED |
184 |
Meningococcal,NOS |
|
| 114 |
meningococcal MCV4P |
SUPPORTED |
183 |
MCV4 (Menactra) |
|
| 32 |
meningococcal MPSV4 |
SUPPORTED |
182 |
Meningococcal polysaccharide(MPSV4) |
|
| 108 |
meningococcal, unspecified formulation |
SUPPORTED |
184 |
Meningococcal,NOS |
|
| 07 |
mumps |
SUPPORTED |
162 |
Mumps |
|
| 998 |
no vaccine administered |
NOT SUPPORTED |
|
|
|
| 69 |
parainfluenza-3 |
NOT SUPPORTED |
1630 |
parainfluenza-3 |
|
| 11 |
pertussis |
NOT SUPPORTED |
1640 |
pertussis |
|
| 23 |
plague |
NOT SUPPORTED |
1650 |
plague |
|
| 100 |
pneumococcal conjugate PCV 7 |
SUPPORTED |
154 |
PCV7 |
|
| 33 |
pneumococcal polysaccharide PPV23 |
SUPPORTED |
155 |
PPV23 |
|
| 109 |
pneumococcal, unspecified formulation |
SUPPORTED |
156 |
Pneumococcal,NOS |
|
| 89 |
polio, unspecified formulation |
SUPPORTED |
153 |
Polio |
|
| 40 |
rabies, intradermal injection |
NOT SUPPORTED |
210 |
Rabies |
|
| 18 |
rabies, intramuscular injection |
NOT SUPPORTED |
210 |
Rabies |
|
| 90 |
rabies, unspecified formulation |
NOT SUPPORTED |
210 |
Rabies |
|
| 72 |
rheumatic fever |
NOT SUPPORTED |
1720 |
rheumatic fever |
|
| 119 |
rotavirus, monovalent |
SUPPORTED |
206 |
Rotavirus,monovalent(RV1,2 dose) |
|
| 116 |
rotavirus, pentavalent |
SUPPORTED |
207 |
Rotavirus,pentavalent(RV5,3 dose) |
|
| 74 |
rotavirus, tetravalent |
SUPPORTED |
208 |
Rotavirus(used in 1998-1999 only) |
|
| 122 |
rotavirus, unspecified formulation |
SUPPORTED |
212 |
Rotavirus, NOS |
|
| 06 |
rubella |
SUPPORTED |
171 |
Rubella |
|
| 38 |
rubella/mumps |
SUPPORTED |
175 |
Rubella/Mumps |
|
| 35 |
tetanus toxoid, adsorbed |
NOT SUPPORTED |
1830 |
tetanus toxoid |
|
| 142 |
tetanus toxoid, not adsorbed |
NOT SUPPORTED |
|
|
|
| 112 |
tetanus toxoid, unspecified formulation |
NOT SUPPORTED |
|
|
|
| 77 |
tick-borne encephalitis |
NOT SUPPORTED |
1840 |
tick-borne encephalitis |
|
| 78 |
tularemia vaccine |
NOT SUPPORTED |
1900 |
tularemia vaccine |
|
| 101 |
typhoid, ViCPs |
NOT SUPPORTED |
1940 |
typhoid, ViCPs |
|
| 25 |
typhoid, oral |
NOT SUPPORTED |
1910 |
typhoid, oral |
|
| 41 |
typhoid, parenteral |
NOT SUPPORTED |
1920 |
typhoid, parenteral |
|
| 53 |
typhoid, parenteral, AKD (U.S. military) |
NOT SUPPORTED |
1930 |
typhoid, parenteral, AKD(U.S. military) |
|
| 91 |
typhoid, unspecified formulation |
NOT SUPPORTED |
1950 |
typhoid, NOS |
|
| 131 |
typhus, historical |
NOT SUPPORTED |
3141 |
Typhus,Historical |
|
| 999 |
unknown |
NOT SUPPORTED |
9999 |
Unknown |
|
| 75 |
vaccinia (smallpox) |
NOT SUPPORTED |
1800 |
smallpox |
|
| 105 |
vaccinia (smallpox) diluted |
NOT SUPPORTED |
|
|
|
| 79 |
vaccinia immune globulin |
NOT SUPPORTED |
1960 |
vaccinia immune globulin |
|
| 21 |
varicella |
SUPPORTED |
178 |
Varicella |
|
| 37 |
yellow fever |
NOT SUPPORTED |
2020 |
yellow fever |
|
| 121 |
zoster |
SUPPORTED |
2110 |
zoster |
|